Biofermin Pharmaceutical Co Ltd 4517.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
2,489.00quote price arrow down-2.00 (-0.08%)
Volume
1,900
52 week range
2,045.00 - 2,726.00

...

Loading . . .

KEY STATS

  • Open2,491.00
  • Day High2,491.00
  • Day Low2,472.00
  • Prev Close2,491.00
  • 52 Week High2,726.00
  • 52 Week High Date02/22/21
  • 52 Week Low2,045.00
  • 52 Week Low Date03/13/20
  • Market Cap283.23M
  • Shares Out11.96M
  • 10 Day Average Volume6,730
  • Dividend60.00
  • Dividend Yield2.41%
  • Beta
  • 1 Year % Change9.36

RATIOS/PROFITABILITY

  • EPS (TTM)150.50
  • P/E (TTM)16.54
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/29/2020
  • Div Amount30.00
  • Split Date-
  • Split Factor-

Latest Biofermin Pharmaceutical Co Ltd News

There is no recent news for this security.

Latest 4517.T-JP News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
BIOFERMIN PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals, quasi-drugs and food products. Its products include constipating agent, anti-diarrheal agent, stomachic and digestion tablets, vitamin C (VC), laxative, food raw materials and veterinary drugs. Additionally, the Company offers its products to both domestic and overseas markets.
Ken Uehara
Chairman
Hideyuki Waki
President
Address
5-5, Samban-cho, Nagata-ku
Kobe-shi, HYG
650-0021
Japan